Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Kevin R. Flaherty
University of Michigan at Ann Arbor - Department of Internal Medicine
3116 Taubman Center
Ann Arbor, MI 48109-0376
United States
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
171
TOTAL CITATIONS
3
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Pamrevlumab (FG-3019), an Anti-Connective Tissue Growth Factor Therapy for Idiopathic Pulmonary Fibrosis: A Randomized, Double-Blind, Placebo-Controlled Trial
Number of pages: 30
Posted: 03 May 2019
Luca Richeldi
,
Evans R. Fernández Pérez
,
Ulrich Costabel
,
Carlo Albera
,
David J. Lederer
, Kevin R. Flaherty,
Neil Ettinger
,
Rafael Perez
,
Mary Beth Scholand
,
Jonathan Goldin
,
Kin-Hung Peony Yu
,
Thomas Neff
,
Seth Porter
,
Ming Zhong
,
Eduard Gorina
,
Elias Kouchakji
and
Ganesh Raghu
Catholic University of Milan - Pneumology Complex Operating Unit, National Jewish Health, University of Duisburg-Essen - University Hospital Essen, University of Turin, Columbia University - Mailman School of Public Health, University of Michigan at Ann Arbor - Department of Internal Medicine, St. Luke's Hospital, University of Louisville, University of Utah, MedQIA, FibroGen, Inc., FibroGen, Inc., FibroGen, Inc. - Department of Clinical Development, FibroGen, Inc. - Department of Clinical Development, FibroGen, Inc., FibroGen, Inc. - Department of Clinical Development and University of Washington - Interstitial Lung Disease Clinic
Downloads
171
(440,047)
Citation
3
View PDF
Download
Abstract:
Feedback